NASDAQ:LFMD

LifeMD (LFMD) Stock Price, News & Analysis

$9.13
-0.17 (-1.83%)
(As of 02:03 PM ET)
Today's Range
$8.97
$9.83
50-Day Range
$7.54
$12.51
52-Week Range
$1.66
$12.88
Volume
930,922 shs
Average Volume
839,760 shs
Market Capitalization
$373.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.60

LifeMD MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
25.8% Upside
$11.60 Price Target
Short Interest
Bearish
8.10% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.09mentions of LifeMD in the last 14 days
Based on 16 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($0.14) to ($0.31) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.14 out of 5 stars

Medical Sector

876th out of 915 stocks

Offices & Clinics Of Medical Doctors Industry

6th out of 7 stocks

LFMD stock logo

About LifeMD Stock (NASDAQ:LFMD)

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

LFMD Stock Price History

LFMD Stock News Headlines

Biggest hedge fund manager has huge warning for U.S. dollar
Prescient CEO Makes Shocking New Prediction Known for his eerily accurate market calls over the years, this CEO has just revealed his newest prediction about "America's New Money."
Biggest hedge fund manager has huge warning for U.S. dollar
Prescient CEO Makes Shocking New Prediction Known for his eerily accurate market calls over the years, this CEO has just revealed his newest prediction about "America's New Money."
LifeMD Full Year 2023 Earnings: Beats Expectations
LifeMD Shares Jump on Strong 4Q
LifeMD Reports Fourth Quarter 2023 Results
Here's what to expect from LifeMD's earnings
Get Your Shopping List Ready: Here's How to Buy Pullbacks
LifeMD Insiders Placed Bullish Bets Worth US$1.24m
See More Headlines
Receive LFMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeMD and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/11/2024
Today
5/10/2024
Next Earnings (Estimated)
8/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Offices & clinics of medical doctors
Sub-Industry
N/A
Current Symbol
NASDAQ:LFMD
Fax
N/A
Employees
207
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$11.60
High Stock Price Target
$15.00
Low Stock Price Target
$7.00
Potential Upside/Downside
+27.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Net Income
$-20,600,000.00
Pretax Margin
-11.41%

Debt

Sales & Book Value

Annual Sales
$152.55 million
Book Value
$0.15 per share

Miscellaneous

Free Float
33,164,000
Market Cap
$373.33 million
Optionable
Optionable
Beta
1.38
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Justin SchreiberMr. Justin Schreiber (Age 41)
    Chairman & CEO
    Comp: $255k
  • Mr. Marc Benathen (Age 43)
    Chief Financial Officer
    Comp: $378.75k
  • Mr. Eric H. Yecies (Age 46)
    Chief Legal Officer, General Counsel & Secretary
    Comp: $332k
  • Ms. Maria E. Stan CPA (Age 49)
    Controller & Principal Accounting Officer
  • Mr. Dennis Wijnker (Age 48)
    Chief Technology Officer
  • Mr. Shane Biffar
    Chief Compliance Officer & Deputy General Counsel
  • Ms. Jessica Friedeman (Age 40)
    Chief Marketing Officer
  • Mr. Stefan GalluppiMr. Stefan Galluppi (Age 37)
    Chief Innovation Officer
    Comp: $165k
  • Mr. Nicholas P. Alvarez (Age 42)
    Chief Acquisition Officer & Head of Customer Acquisition
    Comp: $141.11k
  • Mr. Varun Pathak
    Chief Software Engineer & Co-Founder of PDF Simpli

LFMD Stock Analysis - Frequently Asked Questions

Should I buy or sell LifeMD stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for LifeMD in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" LFMD shares.
View LFMD analyst ratings
or view top-rated stocks.

What is LifeMD's stock price target for 2024?

5 equities research analysts have issued 12-month price objectives for LifeMD's shares. Their LFMD share price targets range from $7.00 to $15.00. On average, they predict the company's share price to reach $11.60 in the next twelve months. This suggests a possible upside of 25.8% from the stock's current price.
View analysts price targets for LFMD
or view top-rated stocks among Wall Street analysts.

How have LFMD shares performed in 2024?

LifeMD's stock was trading at $8.29 on January 1st, 2024. Since then, LFMD shares have increased by 11.2% and is now trading at $9.22.
View the best growth stocks for 2024 here
.

Are investors shorting LifeMD?

LifeMD saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 2,560,000 shares, an increase of 9.9% from the April 15th total of 2,330,000 shares. Based on an average trading volume of 669,700 shares, the days-to-cover ratio is presently 3.8 days. Currently, 8.1% of the shares of the stock are sold short.
View LifeMD's Short Interest
.

When is LifeMD's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 14th 2024.
View our LFMD earnings forecast
.

How were LifeMD's earnings last quarter?

LifeMD, Inc. (NASDAQ:LFMD) posted its quarterly earnings results on Monday, March, 11th. The company reported ($0.12) earnings per share for the quarter, topping the consensus estimate of ($0.14) by $0.02. The firm earned $44.86 million during the quarter, compared to the consensus estimate of $40.65 million.

What ETFs hold LifeMD's stock?

ETFs with the largest weight of LifeMD (NASDAQ:LFMD) stock in their portfolio include Invesco DWA SmallCap Momentum ETF (DWAS).Invesco Dorsey Wright Healthcare Momentum ETF (PTH).

What guidance has LifeMD issued on next quarter's earnings?

LifeMD issued an update on its second quarter 2024 earnings guidance on Wednesday, May, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $48.0 million-$50.0 million, compared to the consensus revenue estimate of $47.1 million.

Who are LifeMD's major shareholders?

LifeMD's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Russell Investments Group Ltd. (0.16%), Blair William & Co. IL (0.15%), Sei Investments Co. (0.11%), Hussman Strategic Advisors Inc. (0.10%) and Thompson Davis & CO. Inc. (0.10%). Insiders that own company stock include Bertrand Velge, Corey Deutsch, Eric Harold Yecies, Happy David Walters, Joseph Ditrolio, Justin Schreiber, Marc David Benathen, Naveen Bhatia, Nicholas P Alvarez and Stefan Galluppi.
View institutional ownership trends
.

How do I buy shares of LifeMD?

Shares of LFMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:LFMD) was last updated on 5/10/2024 by MarketBeat.com Staff

From Our Partners